IRAK4-IN-20

CAS No. 1931994-80-7

IRAK4-IN-20( —— )

Catalog No. M35663 CAS No. 1931994-80-7

IRAK4-IN-20 is a potent and orally active IRAK4 inhibitor (IC50:3.55 nM). IRAK4-IN-20, which has anti-inflammatory, antitumor and anticancer effects, is often used to treat acute respiratory distress syndrome (ARDS).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 454 In Stock
5MG 392 In Stock
10MG 626 In Stock
25MG 938 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IRAK4-IN-20
  • Note
    Research use only, not for human use.
  • Brief Description
    IRAK4-IN-20 is a potent and orally active IRAK4 inhibitor (IC50:3.55 nM). IRAK4-IN-20, which has anti-inflammatory, antitumor and anticancer effects, is often used to treat acute respiratory distress syndrome (ARDS).
  • Description
    IRAK4-IN-20 is a potent and orally active IRAK4 inhibitor (IC50:3.55 nM). IRAK4-IN-20, which has anti-inflammatory, antitumor and anticancer effects, is often used to treat acute respiratory distress syndrome (ARDS).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IRAK
  • Recptor
    IRAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1931994-80-7
  • Formula Weight
    450.45
  • Molecular Formula
    C22H25F3N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C)(C)(O)C1=CC=2C(C=C1NC(=O)C=3N=C(C(F)(F)F)C=CC3)=CN(CCC(C)(C)O)N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • IRAK inhibitor 1

    IRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC50 of 216 nM.

  • PF-05388169

    A potent, selective IRAK4 inhibitor with IC50 of 0.094 nM.

  • IRAK inhibitor 3

    IRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.